New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 21, 2013
08:54 EDTMNKDSummer Street 'much more optimistic' about MannKind approval
After speaking with a former FDA reviewer, Summer Street said it is "much more optimistic" that current trials of MannKind's inhalable insulin for treating type 1 and type 2 diabetes could lead to FDA approval. Summer Street said the consultant it spoke to sees an 85% chance that in the type 1 diabetes study Afrezza hits its endpoint. Shares of MannKind are up 13c to $6.83 in pre-market trading.
News For MNKD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 4, 2015
16:05 EDTMNKDMannKind files automatic mixed securities shelf
Subscribe for More Information
August 31, 2015
05:36 EDTMNKDStocks with implied volatility movement; MNKD ABT
Subscribe for More Information
August 27, 2015
05:54 EDTMNKDStocks with implied volatility above IV index mean; MNKD AMBA
Subscribe for More Information
August 26, 2015
05:52 EDTMNKDStocks with implied volatility movement; TSM MNKD
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use